1786-81-8
Chemical Structure
Prilocaine hydrochloride
- CAS No.: 1786-81-8
- Formula:C13H21ClN2O
- Molecular Weight:256.77
IUPAC Name: 2-(propylamino)-N-(o-tolyl)propanamide hydrochloride
InChIKey: BJPJNTKRKALCPP-UHFFFAOYSA-N
SMILES: CC(NCCC)C(NC1=CC=CC=C1C)=O.Cl
Biological Activity: Prilocaine hydrochloride, an amino amide, is a Na/K-ATPase inhibitor. Prilocaine has neurotoxic effects[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Prilocaine hydrochloride | Prilocaine hydrochloride, an amino amide, is a Na/K-ATPase inhibitor. Prilocaine has neurotoxic effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Prilocaine hydrochloride (Standard) | ≥98% | Prilocaine (hydrochloride) (Standard) is the analytical standard of Prilocaine (hydrochloride). This product is intended for research and analytical applications. Prilocaine hydrochloride, an amino amide, is a Na/K-ATPase inhibitor. Prilocaine has neurotoxic effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Prilocaine-d7 hydrochloride | 98.16% | Prilocaine-d7 (hydrochloride) is deuterium labeled Prilocaine (hydrochloride). Prilocaine hydrochloride, an amino amide, is a Na, K-ATPase inhibitor. Prilocaine has neurotoxic effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Prilocaine Hydrochloride-d7 | Prilocaine Hydrochloride-d7 is the deuterium labeled Prilocaine hydrochloride (HY-B0137A). Prilocaine hydrochloride, an amino amide, is a Na/K-ATPase inhibitor. Prilocaine has neurotoxic effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. M Mete, et al. Neurotoxic effects of local anesthetics on the mouse neuroblastoma NB2a cell line. Biotech Histochem. 2015 Apr;90(3):216-22. [Content Brief]
- [2]. H Kutchai, et al. Effects of local anaesthetics on the activity of the Na,K-ATPase of canine renal medulla. Pharmacol Res. 2000 Jan;41(1):1-7. [Content Brief]